Justin Matthew Long MD PhD
Neurodegenerative, Dementia & Geriatrics
Assistant Professor at Washington University
Join to View Full Profile
4921 Parkview Pl# DvSaint Louis, MO 63110
Phone+1 314-362-1408
Fax+1 314-286-1985
Dr. Long is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Dementia, 2018 - 2020- Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2014 - 2018
Indiana University School of MedicineClass of 2014
Indiana UniversityPhD, Medical Neuroscience, 2007 - 2013
Indiana UniversityBS, Biology, Highest Academic Distinction, General Honor Notation, 2001 - 2004
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 2017 - 2026
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 6 citationsCholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy.Danira Toral-Rios, Justin M Long, Jason D Ulrich, Jinsheng Yu, Michael R Strickland
The Journal of Experimental Medicine. 2024-04-01 - 25 citationsRegulation of astrocyte lipid metabolism and ApoE secretionby the microglial oxysterol, 25-hydroxycholesterol.Anil G Cashikar, Danira Toral-Rios, David Timm, Johnathan Romero, Michael Strickland
Journal of Lipid Research. 2023-04-01 - 22 citationsPreclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.Justin M Long, Dean W Coble, Chengjie Xiong, Suzanne E Schindler, Richard J Perrin
Brain. 2022-12-19
Journal Articles
- Novel Upregulation of Amyloid-Β Precursor Protein (APP) by microRNA-346 via Targeting of APP mRNA 5′-Untranslated Region: Implications in Alzheimer’s DiseaseJustin Long, MD, Nature
Press Mentions
COVID-19 Closes Labs, Slows Data Collection—The Impact on the Neurology Research PipelineJuly 11th, 2020
Aducanumab About-Face: Experts Weigh InJuly 11th, 2020
A Discontinued Alzheimer’s Trial Comes Alive Again. Will Biogen’s Aducanumab Survive the FDA Review?July 11th, 2020
Grant Support
- The role of 25-hydroxycholesterol in modulating ApoE-dependent Alzheimer disease-related pathogenesisWASHINGTON UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
